Generate a tailored SOP for Dr. Eva Stadler. Improve your application with a focused, well-structured draft.
Eva Stadler is a researcher in the Infection Analytics Program at the Kirby Institute, University of New South Wales, focusing on the intersection of mathematical biology and public health. She received her doctoral degree from the Technical University of Munich in 2019. Her research employs mathematical quantitative methods to gain insights into host dynamics in infectious diseases, particularly malaria and SARS-CoV-2. One of her significant contributions includes investigating the efficacy of passive antibody treatments for COVID-19, quantifying the relationship between neutralizing antibody levels and the effectiveness of monoclonal antibody treatment. Her work has contributed to the Australian National Clinical Evidence Taskforce, especially in analyzing risks associated with SARS-CoV-2 infections among immunosuppressed patients. Currently, Eva focuses on applying statistical analysis and model fitting to evaluate vaccine effectiveness data and the conditions affecting it in vulnerable populations. Additionally, she studies assay-related variations that impact the measured levels of neutralization, a known correlate of protection against SARS-CoV-2.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.